IP Library Granted Patent US 10,017,760
Granted Patent B2
US 10,017,760 · App. 15/632,222 · Granted Jul 10, 2018

Methods for generating barcoded combinatorial libraries

Inventors: Ryan T. Gill (Denver, CO); Andrew Garst (Boulder, CO); Tanya Elizabeth Warnecke Lipscomb (Boulder, CO); Marcelo Colika Bassalo (Boulder, CO); Ramsey Ibrahim Zeitoun (San Francisco, CA)
Assignees: Inscripta, Inc.; The Regents of the University of Colorado, a Body Corporate
C12N15/1065C12N15/102C12N15/1079C12N15/1082C12N15/11C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,017,760
App. No.
15/632,222
Granted
Jul 10, 2018
Kind
B2
Abstract

Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engineering. Further provided herein are methods and compositions for enriching for editing and trackable engineered sequences and cells using nucleic acid-guided nucleases.

Claims (31)

1. A method of genome engineering, the method comprising:

a) contacting a population of cells with a polynucleotide, wherein each cell comprises a first target nucleic acid, a second target nucleic acid, and a nucleic acid-guided nuclease,

wherein the polynucleotide comprises

1) an editing cassette comprising:

i) a modified first target nucleic acid sequence;

ii) a first protospacer adjacent motif (PAM) mutation;

iii) a first guide nucleic acid sequence targeting the first target nucleic acid and compatible with the nucleic acid-guided nuclease; and

2) a recorder cassette comprising

i) a barcode for tracking and identifying the modified first target nucleic acid sequence; and

ii) a second guide nucleic acid sequence targeting the second target nucleic acid and compatible with the nucleic acid-guided nuclease;

b) allowing the first guide nucleic acid sequence, the second guide nucleic acid sequence, and the nucleic acid-guided nuclease to create a genome edit within the first target nucleic acid and the second target nucleic acid; and

c) using the PAM mutation to enrich for cells comprising the genome edit within the first target nucleic acid and second target nucleic acid.

2. The method of claim 1 , further comprising d) sequencing the barcode, thereby identifying the modified first target nucleic acid that was inserted within the first target nucleic acid in step a).

3. The method of claim 1 , wherein the nucleic acid-guided nuclease is a CRISPR nuclease.

4. The method of claim 1 , wherein the PAM mutation is not recognized by the nucleic acid-guided nuclease.

5. The method of claim 1 , wherein the nucleic acid-guided nuclease is a Type II or Type V Cas protein.

6. The method of claim 1 , wherein the nucleic acid-guided nuclease is a Cas9 homologue or a Cpf1 homologue.

7. The method of claim 1 , wherein the recorder cassette further comprises a second PAM mutation that is not recognized by the nucleic acid-guided nuclease.

8. A method of selectable recursive genetic engineering comprising

a) contacting cells comprising a nucleic acid-guided nuclease with a polynucleotide comprising a recorder cassette, said recorder cassette comprising

i) a nucleic acid sequence that recombines into a unique landing site incorporated during a previous round of engineering, wherein the nucleic acid sequence comprises a unique barcode; and

ii) a guide RNA compatible with the nucleic acid-guided nuclease that targets the unique landing site; and

b) allowing the nucleic acid-guided nuclease to edit the unique landing site, thereby incorporating the unique barcode into the unique landing site.

9. The method of claim 8 , wherein the nucleic acid sequence further comprises a regulatory sequence that turns transcription of a screenable or selectable marker on or off.

10. The method of claim 8 , wherein the nucleic acid sequence further comprises a PAM mutation that is not compatible with the nucleic acid-guided nuclease.

11. The method of claim 8 , wherein the nucleic acid sequence further comprises a second unique landing site for subsequent engineering rounds.

12. The method of claim 8 , wherein the polynucleotide further comprises an editing cassette comprising

a) a modified first target nucleic acid sequence;

b) a first protospacer adjacent motif (PAM) mutation; and

c) a first guide nucleic acid sequence targeting the first target nucleic acid,

wherein the modified first target nucleic acid can be tracked and identified by the unique barcode.

Assignments (5)
CONFIRMATORY LICENSE Recorded Jun 21, 2022
From: UNIVERSITY OF COLORADO
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 060264/0264 →
CHANGE OF NAME Recorded Mar 7, 2018
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 045518/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2018
From: LIPSCOMB, TANYA ELIZABETH WARNECKE
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 044871/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2018
From: GILL, RYAN T.; GARST, ANDREW; BASSALO, MARCELO COLIKA; ZEITOUN, RAMSEY IBRAHIM
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 044872/0207 →
CHANGE OF NAME Recorded Feb 8, 2018
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 045290/0697 →
Continuity (4)
Provisional Application 62354516 · Jun 24, 2016
Provisional Application 62367386 · Jul 27, 2016
Provisional Application 62483930 · Apr 10, 2017
Related Publication 20170369870A1 · Dec 28, 2017
Cited By (2)
US 12,195,749 US 12,584,140